← Evidence map

ArticleOncoTargets and therapy2026

A Six-year Response to Belinostat in a Highly Probable Case of Relapsed/Refractory MF/SS Initially Classified as PTCL-NOS: A Case Report.

Nicolas Gauthier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

A Six-year Response to Belinostat in a Highly Probable Case of Relapsed/Refractory MF/SS Initially Classified as PTCL-NOS: A Case Report. | OpenQuestion